Question 1

Does Vanguard Group own BBIO stock?

Accepted Answer

As of its last 13F, for Q4 2025, Vanguard Group held 16,862,691 shares of BBIO (Bridgebio Pharma), worth $1.3B.

Question 2

How many shares of BBIO does Vanguard Group own?

Accepted Answer

As of its last 13F, for Q4 2025, Vanguard Group held 16,862,691 shares of BBIO (Bridgebio Pharma).

Question 3

What is Vanguard Group's BBIO position worth?

Accepted Answer

As of its last 13F, for Q4 2025, Vanguard Group's BBIO position was worth $1.3B.

Question 4

Is Vanguard Group buying or selling BBIO?

Accepted Answer

In Q4 2025, Vanguard Group increased its BBIO position by 30,632 shares (+0.2%).

Question 5

When did Vanguard Group first buy BBIO?

Accepted Answer

Vanguard Group already held BBIO in its Q3 2024 13F, the earliest on record, and listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Increased	16.9M	+0.2%	$1.3B	0.0%	$76.49	32
2025-Q3	Increased	16.8M	+2.1%	$874.3M	0.0%	$51.94	32
2025-Q2	Increased	16.5M	+10.6%	$711.8M	0.0%	$43.18	35
2025-Q1	Decreased	14.9M	-1.2%	$515.1M	0.0%	$34.57	0
2024-Q4	Increased	15.1M	+6.2%	$413.7M	0.0%	$27.44	33
2024-Q3	First report	14.2M	-	$361.5M	0.0%	$25.46	0

BBIO6 quarters

BBIO
6 quarters